Cefepime Alleviates Comorbid Pain and Depression Induced by Lipopolysaccharide in Female Mice
Open Access
- 12 March 2026
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 16 (3) , 306
Abstract
Background/Objectives: Evidence indicates that aberrant glutamate transporter function and expression are linked to the pathophysiology of comorbid major depressive disorder (MDD) and pain. We have previously reported that cefepime (CFP) attenuates lipopolysaccharide (LPS)-evoked pain and depression by regulating hyperglutamatergic activity in male mice. However, the effects of CFP on LPS-evoked pain, depression-related anxiety, and cognitive impairment in female mice regarding sex-specific glial mechanisms remain unknown. Methods: Using behavioral paradigms, we evaluated the therapeutic potential of CFP in mitigating LPS-evoked pain, depression-related anxiety, and cognitive impairment in female mice. Furthermore, we used Western blot analysis to examine the effects of CFP on ionized calcium-binding adaptor molecule 1 (Iba-1) and glutamate transporter 1 (GLT-1) protein levels in the prefrontal cortex (PFC) and hippocampus (HPC). We also measured tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) concentrations in the HPC and PFC after CFP treatment using ELISA. Results: Pretreatment with CFP significantly increased the mechanical threshold and withdrawal latency in female mice. Additionally, systemic treatment with CFP markedly reduced immobility during the forced swim and tail suspension tests. Moreover, pretreatment with CFP remarkably augmented the open arm time during elevated plus maze test and spontaneous alternation between arms during Y-maze test. Western blot analysis indicated that systemic administration of CFP significantly reversed the downregulation of astroglial GLT-1 expression and reduced the microglial Iba-1 protein levels in the HPC and PFC. Furthermore, pretreatment with CFP significantly attenuated the LPS-evoked increase in the production of pro-inflammatory cytokines in the HPC and PFC. Conclusions: These results represent the novel inaugural report of a combined pain-MDD phenotype in female mice. The findings imply that positive glutamate transporter modulator CFP could be a novel treatment for comorbid pain and MDD in female patient population.Keywords
Funding Information
- South Dakota State University (SDSU) College of Pharmacy and Department of Pharmaceutical Sciences
- Great Plains Veterans Research Foundation and Research Service
- Sioux Falls VA Healthcare System
- Office of Research and Development (I01BX004712)
This publication has 74 references indexed in Scilit:
- Beta-lactam Antibiotic Cefepime Attenuates Lipopolysaccharide-induced Pain and Depression By Modulating Inflammatory Response and Astroglial Glutamate Transporter in MiceJournal of Neuroimmune Pharmacology, 2026
- Implicating neuroinflammation in hippocampus, prefrontal cortex and amygdala with cognitive deficit: a narrative review3 Biotech, 2025
- Glutamate transporter activator LDN-212320 prevents chronic pain-induced cognitive impairment and anxiety-like behaviors in a mouse modelBehavioural Brain Research, 2025
- Antinociceptive effects of ceftriaxone in formalin-induced nociceptionDrug Development Research, 2020
- Alpha-7 nicotinic receptor allosteric modulator PNU120596 prevents lipopolysaccharide-induced anxiety, cognitive deficit and depression-like behaviors in miceBehavioural Brain Research, 2019
- The molecular neurobiology of chronic pain–induced depressionCell and tissue research, 2019
- Effects of glial glutamate transporter activator in formalin‐induced pain behaviour in miceEuropean journal of pain, 2018
- Neuroinflammation in bipolar disorder – A [11C]-(R)-PK11195 positron emission tomography studyBrain, Behavior, and Immunity, 2014
- Brain regions associated with psychological pain: implications for a neural network and its relationship to physical painBrain Imaging and Behavior, 2012
- Glutamate released by Japanese encephalitis virus‐infected microglia involves TNF‐α signaling and contributes to neuronal deathGlia, 2011